BMRN
Biomarin Pharmaceutical Inc
Price:  
89.49 
USD
Volume:  
1,257,348.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin Stock Forecast & Price Target

Biomarin Stock Price Forecast

The average stock forecast for Biomarin Pharmaceutical Inc (BMRN) in the next 12 months is 111.89 USD. This price target corresponds to an upside of 25.03%. The range of stock forecasts for Biomarin is 80.80 - 147.00 USD. Based on the ratings of 34 analysts, the consensus recommendation for Biomarin is BUY.
Target Low Average Median High
Price (USD) 80.80 111.89 111.18 147.00
Upside -9.71% 25.03% 24.24% 64.26%

Recommendation Trends

The latest consensus rating for Biomarin is "BUY". This is the average recommendation of 34 analysts: 0 strong sell, 0 sell, 9 hold, 15 buy, 10 strong buy. In the previous period, 35 analysts also majorly recommmended "BUY" for Biomarin.

Biomarin Financial Stock Forecast

Revenue This Year
2.76B
14.13%
from 2.42B
Revenue Next Year
3.17B
14.68%
from 2.76B
EPS This Year
1.69
91.55%
from 0.88
EPS Next Year
2.83
67.48%
from 1.69